Legal & General Group PLC Sesen Bio, Inc. Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 22, 2022
SELL
$0.38 - $0.89 $9,840 - $23,047
-25,896 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$0.58 - $0.86 $783 - $1,161
1,351 Added 5.5%
25,896 $15,000
Q3 2021

Nov 15, 2021
BUY
$0.77 - $4.91 $2,085 - $13,301
2,709 Added 12.41%
24,545 $19,000
Q2 2021

Aug 12, 2021
BUY
$2.18 - $4.66 $47,602 - $101,755
21,836 New
21,836 $101,000

Others Institutions Holding SESN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About Sesen Bio, Inc.

SESN Quotes by TradingView
  • Ticker SESN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,702,000
  • Market Cap $127M
  • Description
  • Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...
More about SESN
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email